In a new Cedars-Sinai study of Parkinson's disease patients, those who had taken common medications to control pain, blood pressure, diabetes or cholesterol saw their symptoms begin years later ...

Some respond to conventional Parkinson’s medications, while others require completely different interventions. Prognosis and disease trajectory vary widely among these disorders.

A new drug is showing promise in treating Parkinson’s while reducing unwanted side effects. The pill, tavapadon, extended symptom relief without the adverse effects of the first line of treatment.

The new device has also allowed him to reduce his Parkinson's medications from 14 or 15 a day to four, he says. Read More: Michael J. Fox: Chasing Parkinson's Treatments ...

Scientists have created a long-acting injectable gel that releases Parkinson's medications for an entire week, potentially transforming treatment for millions worldwide.

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson’s disease, potentially replacing the need for daily pills. Scientists from the ...

To participate, individuals with Parkinson’s must be 62 or older, have been officially diagnosed with the disease and have no recent changes in Parkinson’s medications. Participants should ...

Commonly prescribed medications such as statins, non-steroidal anti-inflammatory drugs and certain blood pressure drugs may significantly delay the onset of Parkinson’s disease. The study ...